Microsoft word - bibliografia modena.doc

Monografia GSS 2008 – Rachide & Riabilitazione Multidisciplinare – Quarto Evidence Based Meeting
Borenstein DG. Epidemiology, etiology, diagnostic evaluation, and treatment of low bach pain. Curr Opin Rheumatol., 1997; 9: 144-150 Anderson GBJ. Epidemiological features of chronic low-back pain. The Lancet, 1999; 354:581-585 ) Cecchi F, Debolini P, Lova RM, Macchi C, Bandinelli S, Bartali B, Lauretani F, Benvenuti E, Hicks G, Ferrucci L. Epidemiology of back pain in a representative cohort of Italian persons 65 years of age and older: the InCHIANTI study. Spine. 2006 May 1;31(10):1149-55. Deyo RA, Weinstein JN. Low back pain. N. Engl J. Med.2001; 344:636-370 Little P, Smith L, Cantrel T, Chapman J, Lanhgridge J, Pickering R. General practitioners’ management of acute back pain: a survey of reported practive compared with clinical guidelines. BMJ. 1996; 312:485-488 Atlas SJ, Volinn E. Classic from the spine literature revisited: a randomized trial of 2 versus 7 days of recommended bed rest for acute low back pain. Spine. 1997; 22:2331-2337 Andranakos A, Trontzas P, Christoyannis F, Dantis P, Voudouris C, Georgountzos A, Kaziolas G, Vafiadou E, Pantelidou K, Karamitsos D, Kontelis L, Krachtis P, Nikolia Z, Kaskani E, Tavaniotou E, Antoniades C, Karanikolas G, Kontoyanni A. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study.The ESORDIG Study. J. Rheumatol. 2003; 30:1589-1601 Praemer A, Furnes S, Rice DP. Musculoskeletal conditions in the United States . Rosemont: AAUS; 1992; 1-99 Taylor VM, Deyo RA, Cherkin DC. Kreuter W. Low-back-pain hospitalization: recent United States trends and regional variations. Spine 1994; 19:1207-1213 10 Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain. Spine 1995; 20:11-19. 11 Agnes C, Calvelli P, Ariata Maiocco I, Lerda A, Fusaro E, Modena V, Gai V. La lombalgie dans un service des urgences. Journée EURALP de 12 Prevalence of Disabilities and Associated Health Conditions Among Adults United States, 1999. Centers for disease control and prevention.(CDC). February 23, 2001/ 50 (07): 120-125 13 Maurits W. van Tulder, Mariska Tuut, Victoria Pennick, Claire Bombardier, Willem JJ Assendelft, Quality of Primary Care Guidelines for Acute Low Back Pain Spine 29, 17, pp E357–E362, 2004 14 Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from America College of Physicians and the American Pain Society. Ann Intern Med. 2007 Oct 2;147(7):478-91. 15 Boswell MV, Trescot AM, Datta S, Schultz DM, Hansen HC, Abdi S, Sehgal N, Shah RV, Singh V, Benyamin RM, Patel VB, Buenaventura RM, Colson JD, Cordner HJ, Epter RS, Jasper JF, Dunbar EE, Atluri SL, Bowman RC, Deer TR, Swicegood JR, Staats PS, Smith HS, Burton AW, Kloth DS, Giordano J, Manchikanti L; American Society of Interventional Pain Physicians. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician. 2007 Jan;10(1):7-11 16 Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G; COST B13 Working Group on Guidelines for Chronic Low Back Pain. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006 Mar;15 Suppl 2:S192-300. 17 van Tulder M, Becker A, Bekkering T, Breen A, del Real MT, Hutchinson A, Koes B, Laerum E, Malmivaara A; COST B13 Working Group on Guidelines for the Management of Acute Low Back Pain in Primary Care. Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care.Eur Spine J. 2006 Mar;15 Suppl 2:S169-91Burton AK, Balagué F, Cardon G, Eriksen HR, Henrotin Y, Lahad A, Leclerc A, Müller G, van der Beek AJ; COST B13 Working Group on Guidelines for Prevention in Low Back Pain.Chapter 2. European guidelines for prevention in low back pain : November 2004. Eur Spine J. 2006 Mar;15 Suppl 2:S136-68 18 U.S. Preventive Services Task Force.Primary care interventions to prevent low back pain in adults: recommendation statement. Am Fam 19 Negrini S, Giovannoni S, Minozzi S, Barneschi G, Bonaiuti D, Bussotti A, D'Arienzo M, Di Lorenzo N, Mannoni A, Mattioli S, Modena V, Padua L, Serafini F, Violante FS. Diagnostic therapeutic flow-charts for low back pain patients: the Italian clinical guidelines. Eura Medicophys. 2006 Jun; 42(2):151-70 20 Bianco E, Bistazzoni S, Biondi M, Colosimo C, Cantore G, D’Alessandro R, Fantozzi LM, Ferri M, Fletzer DA, Manca M, Materia E, Modena V, Orsi P, Pasquini M, Rossi A, Tamburelli F, Tempesta F, Zanoli G. Appropriatezza della diagnosi e del trattamento chirurgico dell’ernia del disco lombare sintomatica. Linea guida. PNLG , Ministero della Salute. Documento 9, ottobre 2005 21 Deyo RA, Phillips WR. Low back pain. A primary care challenge. Spine. 1996 Dec 15;21(24):2826-32 22 Roger Chou and Laurie Hoyt Huffman. Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2007;147:505-514 23 Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Nonsteroidal anti-inflammatory drugs for low back pain: an updated cochrane review. Spine. 2008 Jul 15;33(16):1766-74. 24 Lee C, Straus WL, Balshaw R, Barlas S, Vogel S, Schnitzer TJ. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum. 2004 Oct 15;51(5):746-54. 25 Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G Acetaminophen for osteoarthritis Cochrane Database Syst Rev. 2006 26 Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients. Arthritis 27 Bart W Koes Evidence-based management of acute low back pain Lancet. 2007; 370:1595-1596 28 Sheldon EA, Bird SR, Smugar SS, Tershakovec AM Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain. Spine. 2008 Mar 1;33(5):533-8. 29 Luijsterburg PA, Verhagen AP, Ostelo RW, van Os TA, Peul WC, Koes BW.Effectiveness of conservative treatments for the lumbosacral radicular syndrome: a systematic review Eur Spine J. 2007 Jul;16(7):881-99. G.Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998 Jul 27;105(1B):31S-38S 31 Hansen JM, Hallas J, Lauritsen JM, Bytzer P.Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. Scand J Gastroenterol. 1996 Feb;31(2):126-30 32 Zullo A, Hassan C, Campo SM, Morini S.Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.Drugs Aging. 33 Pannu N, Nadim MK.An overview of drug-induced acute kidney injury. Crit Care Med. 2008 Apr;36(4 Suppl):S216-23. 34 Hernández-Díaz S, Varas-Lorenzo C, García Rodríguez LA. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):266-74. 35 Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl. 1999 Apr;56:18-24 36 Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991 Nov 15;115(10):787-96 37 Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, Murphy M, Vessey MP, Colin-Jones DG.Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.Lancet. 1994 Apr 30;343(8905):1075-8. 38 Caporali R, Cimmino MA, Sarzi-Puttini P, Scarpa R, Parazzini F, Zaninelli A, Ciocci A, Montecucco C.Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists. Semin Arthritis Rheum. 2005 Aug;35(1 Suppl 1):31-7. 39 Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005 Mar 17;352(11):1092-102 40 Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M; Adenoma Prevention with Celecoxib (APC) Study Investigators.Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.N Engl J Med. 2005 Mar 17;352(11):1071-80. 41 Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.N Engl J Med. 2005 Mar 17;352(11):1081-91 42 Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C.Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006 Jun 3;332(7553):1302-8. 43 Urquhart DM, Hoving JL, Assendelft WW, Roland M, van Tulder MW. Antidepressants for non-specific low back pain. Cochrane Database Syst 44 MW van Tulder, T Touray, AD Furlan, S Solway, LM. Bouter. Muscle Relaxants for Nonspecific Low Back Pain: A Systematic Review within the Framework of theCochrane Collaboration. Spine 2003;28,17:1978–1992 45 Cabitza P, Randelli P Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study Eur Rev Med Pharmacol 46 FA Beebe, RL Barkin, S Barkin. A. clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. American Journal of Therapeutics 12, 151–171 (2005) (44) 47 A Deshpande, A Furlan, A Mailis-Gagnon, S Atlas, D Turk. Opioids for chronic low-back pain. Cochrane Database of Systematic Reviews 48 Vorsanger GJ, Xiang J, Gana TJ, Pascual ML, Fleming RR. Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain 49 Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction Ann Intern Med. 2007 Jan 16;146(2):116-27. 50 Friedman BW, Holden L, Esses D, Bijur PE, Choi HK, Solorzano C, Paternoster J, Gallagher EJ. Parenteral corticosteroids for Emergency Department patients with non-radicular low back pain. J Emerg Med. 2006 Nov;31(4):365-70 51 Korbonen T, Karppinen J, Paimela L, Malmivaara A, Lindren KA, Bowma C et al . The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II a randomized controlled trial. Spine. 2006; 15; 31(24): 2759-66 52 Mulleman D, Mannou S, Griffoul I, Watier H, Goupille P. Pathophysiology of disk-related low back pain and sciatica. II. Evidence supporting treatment with TNF-alfa antagnists. Joint Bone Spine. 2006; 73 (3): 270-7.


Companies That Do Test on Animals Frequently Asked Questions Why are these companies included on the "Do Test" list? The following companies manufacture products that ARE tested on animals. Those marked with a Ƈ observing a moratorium on (i.e., current suspension of) animal testing. Please encourage them to announce apermanent ban. Listed in parentheses are examples of products manu

Title Incremental Cost-Effectiveness (ICE) Statistical Inference from Two Unbiased SamplesAuthor Bob Obenchain <>Maintainer Bob Obenchain <>Description Given two unbiased samples of patient level data on cost and effectivenessfor a pair of treatments, make head-to-head treatment comparisons by (i) generating thebivariate bootstrap resampling distribution

Copyright ©2018 Drugstore Pdf Search